188 related articles for article (PubMed ID: 22329727)
21. Immunohistochemical and morphologic evaluation of primary cutaneous apocrine carcinomas and cutaneous metastases from ductal breast carcinoma.
Fernandez-Flores A
Rom J Morphol Embryol; 2012; 53(4):879-92. PubMed ID: 23303010
[TBL] [Abstract][Full Text] [Related]
22. [Expression of Ezrin and E-cadherin in invasive ductal breast cancer and their correlations to lymphatic metastasis].
Li Q; Wu MF; Song AP; Wei JC; Xu G; Lu YP; Ma D
Ai Zheng; 2006 Mar; 25(3):363-6. PubMed ID: 16536996
[TBL] [Abstract][Full Text] [Related]
23. [Relationship between D2-40-labeled lymphatic vessel invasion and lymph node metastasis of breast cancer].
Ding GP; Ye CS; Liu MF; Zhen LF; Liao JJ
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Oct; 30(10):2301-3. PubMed ID: 20965831
[TBL] [Abstract][Full Text] [Related]
24. Absence of lymphangiogenesis in ductal breast cancer at the primary tumor site.
van der Schaft DW; Pauwels P; Hulsmans S; Zimmermann M; van de Poll-Franse LV; Griffioen AW
Cancer Lett; 2007 Aug; 254(1):128-36. PubMed ID: 17442484
[TBL] [Abstract][Full Text] [Related]
25. Metaplastic carcinomas of the breast (light microscopic and immunohistochemical features).
Agrawal K; Kaur M; Bajaj P; Agrawal C; Pathania OP
Indian J Cancer; 2001; 38(2-4):80-4. PubMed ID: 12593444
[TBL] [Abstract][Full Text] [Related]
26. Grading system for lymph vessel tumor emboli for prediction of the outcome of invasive ductal carcinoma of the breast.
Hasebe T; Yamauchi C; Iwasaki M; Ishii G; Wada N; Imoto S
Hum Pathol; 2008 Mar; 39(3):427-36. PubMed ID: 18261627
[TBL] [Abstract][Full Text] [Related]
27. Follicular thyroid carcinoma invades venous rather than lymphatic vessels.
Lin X; Zhu B; Liu Y; Silverman JF
Diagn Pathol; 2010 Jan; 5():8. PubMed ID: 20205756
[TBL] [Abstract][Full Text] [Related]
28. Tumor lymphangiogenesis in transitional cell carcinoma of the upper urinary tract: association with clinicopathological features and prognosis.
Miyata Y; Kanda S; Ohba K; Nomata K; Eguchi J; Hayashida Y; Kanetake H
J Urol; 2006 Jul; 176(1):348-53. PubMed ID: 16753442
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological significance of invasive micropapillary carcinoma component in invasive breast carcinoma.
Ide Y; Horii R; Osako T; Ogura K; Yoshida R; Iwase T; Akiyama F
Pathol Int; 2011 Dec; 61(12):731-6. PubMed ID: 22126380
[TBL] [Abstract][Full Text] [Related]
30. Significance of periductal lymphatic and blood vascular densities in intraductal carcinoma of the breast.
El-Gohary YM; Metwally G; Saad RS; Robinson MJ; Mesko T; Poppiti RJ
Breast J; 2009; 15(3):261-7. PubMed ID: 19645781
[TBL] [Abstract][Full Text] [Related]
31. Expression pattern of the lymphatic and vascular markers VEGFR-3 and CD31 does not predict regional lymph node metastasis in cutaneous melanoma.
Wobser M; Siedel C; Schrama D; Bröcker EB; Becker JC; Vetter-Kauczok CS
Arch Dermatol Res; 2006 Feb; 297(8):352-7. PubMed ID: 16395613
[TBL] [Abstract][Full Text] [Related]
32. Organotropism and prognostic marker discordance in distant metastases of breast carcinoma: fact or fiction? A clinicopathologic analysis.
St Romain P; Madan R; Tawfik OW; Damjanov I; Fan F
Hum Pathol; 2012 Mar; 43(3):398-404. PubMed ID: 21840040
[TBL] [Abstract][Full Text] [Related]
33. Absence of lymphangiogenesis and intratumoural lymph vessels in human metastatic breast cancer.
Williams CS; Leek RD; Robson AM; Banerji S; Prevo R; Harris AL; Jackson DG
J Pathol; 2003 Jun; 200(2):195-206. PubMed ID: 12754740
[TBL] [Abstract][Full Text] [Related]
34. Vascular invasion in triple-negative carcinoma of the breast identified by endothelial lymphatic and blood vessel markers.
Kuroda H; Nakai M; Ohnisi K; Ishida T; Kuroda M; Itoyama S
Int J Surg Pathol; 2010 Oct; 18(5):324-9. PubMed ID: 21068066
[TBL] [Abstract][Full Text] [Related]
35. Evidence for lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma.
Kyzas PA; Geleff S; Batistatou A; Agnantis NJ; Stefanou D
J Pathol; 2005 Jun; 206(2):170-7. PubMed ID: 15846845
[TBL] [Abstract][Full Text] [Related]
36. Lymphatic vessel density as a prognostic indicator for patients with stage I cervical carcinoma.
Gao P; Zhou GY; Yin G; Liu Y; Liu ZY; Zhang J; Hao CY
Hum Pathol; 2006 Jun; 37(6):719-25. PubMed ID: 16733213
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathologic correlation of cancer stem cell markers CD44, CD24, VEGF and HIF-1α in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
Wang Z; Shi Q; Wang Z; Gu Y; Shen Y; Sun M; Deng M; Zhang H; Fang J; Zhang S; Xie F
Pathol Res Pract; 2011 Aug; 207(8):505-13. PubMed ID: 21802218
[TBL] [Abstract][Full Text] [Related]
38. Erythematous nodules of the hand: a rare site of metastatic breast carcinoma.
Vijaya B; ; Veeranna S; Manjunath GV
Indian J Dermatol Venereol Leprol; 2011; 77(6):695-8. PubMed ID: 22016277
[TBL] [Abstract][Full Text] [Related]
39. Carcinoma erysipeloides associated with breast carcinoma.
Vega Gutiérrez J; Rodríguez MA
Int J Dermatol; 2007 Jun; 46(6):613-4. PubMed ID: 17550562
[No Abstract] [Full Text] [Related]
40. Invasive lobular carcinoma of the breast: role of endothelial lymphatic marker D2-40.
Laser J; Cangiarella J; Singh B; Melamed J; Chiriboga L; Yee H; Darvishian F
Ann Clin Lab Sci; 2008; 38(2):99-104. PubMed ID: 18469353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
